Balio Diagnostics is a French manufacturer of in vitro diagnostic (IVD) solutions, present in more than 60 countries worldwide. We design and manufacture analyzers, reagents and consumables for clinical, veterinary and research laboratories across clinical chemistry, hematology, hemostasis and electrolytes. We aim to provide high-quality and accessible diagnostic solutions that contribute to better healthcare worldwide. Our portfolio is designed to address a wide range of laboratory workloads and automation needs, from routine testing to more demanding testing environments: • Clinical Chemistry – from semi-automated to fully automated solutions, with throughputs ranging from 200 to 800 tests/hour • Hematology – from 3-part to 5-part differential systems, including reticulocyte analysis and automated solutions reaching 90 tests/hour with a 50-position autosampler • Hemostasis – from 4-channel semi-automated systems to fully automated solutions delivering up to 380 tests/hour • Electrolytes – from semi-automated to fully automated systems, including solutions with a 20-position autosampler Beyond our product portfolio, we work closely with distributors and laboratory professionals to build long-term partnerships and bring reliable diagnostic solutions to markets around the world. Reliable diagnostics begin with reliable solutions — and reliable partnerships.
Looking for a particular Balio Diagnostics employee's phone or email?
The Balio Diagnostics annual revenue was $4 million in 2026.
Benoit Belmar is the Co-fondateur of Balio Diagnostics.
11 people are employed at Balio Diagnostics.
Balio Diagnostics is based in Anglet, Nouvelle-Aquitaine.
The NAICS codes for Balio Diagnostics are [621, 62].
The SIC codes for Balio Diagnostics are [80, 807].